nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfamethoxazole—Cytochrome P450 2C9 Inhibitors—Efavirenz—acquired immunodeficiency syndrome	0.529	1	CiPCiCtD
Sulfamethoxazole—ALB—acquired immunodeficiency syndrome	0.133	1	CbGaD
Sulfamethoxazole—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.0148	0.0608	CbGbCtD
Sulfamethoxazole—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.0148	0.0608	CbGbCtD
Sulfamethoxazole—ALB—Saquinavir—acquired immunodeficiency syndrome	0.0145	0.0596	CbGbCtD
Sulfamethoxazole—ALB—Zidovudine—acquired immunodeficiency syndrome	0.0139	0.0571	CbGbCtD
Sulfamethoxazole—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0121	0.0498	CbGbCtD
Sulfamethoxazole—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0114	0.0469	CbGbCtD
Sulfamethoxazole—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0114	0.0469	CbGbCtD
Sulfamethoxazole—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.0112	0.0461	CbGbCtD
Sulfamethoxazole—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.0112	0.0461	CbGbCtD
Sulfamethoxazole—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.0107	0.0442	CbGbCtD
Sulfamethoxazole—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0103	0.0424	CbGbCtD
Sulfamethoxazole—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0103	0.0424	CbGbCtD
Sulfamethoxazole—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.00888	0.0366	CbGbCtD
Sulfamethoxazole—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.00863	0.0355	CbGbCtD
Sulfamethoxazole—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0078	0.0321	CbGbCtD
Sulfamethoxazole—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0078	0.0321	CbGbCtD
Sulfamethoxazole—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.00748	0.0308	CbGbCtD
Sulfamethoxazole—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00704	0.029	CbGbCtD
Sulfamethoxazole—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00662	0.0272	CbGbCtD
Sulfamethoxazole—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00662	0.0272	CbGbCtD
Sulfamethoxazole—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00598	0.0246	CbGbCtD
Sulfamethoxazole—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00598	0.0246	CbGbCtD
Sulfamethoxazole—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00517	0.0213	CbGbCtD
Sulfamethoxazole—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00502	0.0207	CbGbCtD
Sulfamethoxazole—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00454	0.0187	CbGbCtD
Sulfamethoxazole—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00454	0.0187	CbGbCtD
Sulfamethoxazole—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00435	0.0179	CbGbCtD
Sulfamethoxazole—NAT1—retina—acquired immunodeficiency syndrome	0.0015	0.12	CbGeAlD
Sulfamethoxazole—NAT1—blood—acquired immunodeficiency syndrome	0.00101	0.0806	CbGeAlD
Sulfamethoxazole—NAT1—bone marrow—acquired immunodeficiency syndrome	0.000974	0.078	CbGeAlD
Sulfamethoxazole—NAT1—vagina—acquired immunodeficiency syndrome	0.000933	0.0747	CbGeAlD
Sulfamethoxazole—NAT1—lung—acquired immunodeficiency syndrome	0.000882	0.0707	CbGeAlD
Sulfamethoxazole—UGT1A9—digestive system—acquired immunodeficiency syndrome	0.000627	0.0502	CbGeAlD
Sulfamethoxazole—NAT1—brain—acquired immunodeficiency syndrome	0.000624	0.05	CbGeAlD
Sulfamethoxazole—NAT1—lymph node—acquired immunodeficiency syndrome	0.000603	0.0483	CbGeAlD
Sulfamethoxazole—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.000529	0.0423	CbGeAlD
Sulfamethoxazole—PTGS1—endothelium—acquired immunodeficiency syndrome	0.000483	0.0387	CbGeAlD
Sulfamethoxazole—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.00047	0.0376	CbGeAlD
Sulfamethoxazole—PTGS1—blood plasma—acquired immunodeficiency syndrome	0.000429	0.0343	CbGeAlD
Sulfamethoxazole—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000358	0.0287	CbGeAlD
Sulfamethoxazole—Sulfamethazine—ALB—acquired immunodeficiency syndrome	0.000251	0.366	CrCbGaD
Sulfamethoxazole—Sulfamerazine—ALB—acquired immunodeficiency syndrome	0.000245	0.357	CrCbGaD
Sulfamethoxazole—PTGS1—skin of body—acquired immunodeficiency syndrome	0.000206	0.0165	CbGeAlD
Sulfamethoxazole—CYP2C8—blood—acquired immunodeficiency syndrome	0.000194	0.0155	CbGeAlD
Sulfamethoxazole—Sulfamethizole—ALB—acquired immunodeficiency syndrome	0.00019	0.277	CrCbGaD
Sulfamethoxazole—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000181	0.0145	CbGeAlD
Sulfamethoxazole—CYP2C8—vagina—acquired immunodeficiency syndrome	0.00018	0.0144	CbGeAlD
Sulfamethoxazole—CYP2C9—blood—acquired immunodeficiency syndrome	0.000172	0.0138	CbGeAlD
Sulfamethoxazole—ALB—brain—acquired immunodeficiency syndrome	0.000171	0.0137	CbGeAlD
Sulfamethoxazole—ALB—lymph node—acquired immunodeficiency syndrome	0.000165	0.0132	CbGeAlD
Sulfamethoxazole—PTGS1—digestive system—acquired immunodeficiency syndrome	0.000165	0.0132	CbGeAlD
Sulfamethoxazole—PTGS1—blood—acquired immunodeficiency syndrome	0.000157	0.0126	CbGeAlD
Sulfamethoxazole—PTGS1—spinal cord—acquired immunodeficiency syndrome	0.000151	0.0121	CbGeAlD
Sulfamethoxazole—PTGS1—vagina—acquired immunodeficiency syndrome	0.000146	0.0117	CbGeAlD
Sulfamethoxazole—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000138	0.011	CbGeAlD
Sulfamethoxazole—PTGS1—lung—acquired immunodeficiency syndrome	0.000138	0.011	CbGeAlD
Sulfamethoxazole—CYP3A4—blood—acquired immunodeficiency syndrome	0.000131	0.0105	CbGeAlD
Sulfamethoxazole—PTGS1—nervous system—acquired immunodeficiency syndrome	0.000127	0.0102	CbGeAlD
Sulfamethoxazole—PTGS1—central nervous system—acquired immunodeficiency syndrome	0.000123	0.00983	CbGeAlD
Sulfamethoxazole—CYP2C8—brain—acquired immunodeficiency syndrome	0.00012	0.00963	CbGeAlD
Sulfamethoxazole—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000106	0.00853	CbGeAlD
Sulfamethoxazole—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000103	0.00821	CbGeAlD
Sulfamethoxazole—PTGS1—brain—acquired immunodeficiency syndrome	9.74e-05	0.00781	CbGeAlD
Sulfamethoxazole—PTGS1—lymph node—acquired immunodeficiency syndrome	9.42e-05	0.00754	CbGeAlD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	8.75e-05	0.00107	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	8.74e-05	0.00107	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	8.74e-05	0.00107	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	8.72e-05	0.00106	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	8.71e-05	0.00106	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Lamivudine—acquired immunodeficiency syndrome	8.7e-05	0.00106	CcSEcCtD
Sulfamethoxazole—Insomnia—Zidovudine—acquired immunodeficiency syndrome	8.69e-05	0.00106	CcSEcCtD
Sulfamethoxazole—Skin disorder—Indinavir—acquired immunodeficiency syndrome	8.68e-05	0.00106	CcSEcCtD
Sulfamethoxazole—Chills—Lamivudine—acquired immunodeficiency syndrome	8.66e-05	0.00106	CcSEcCtD
Sulfamethoxazole—Urticaria—Abacavir—acquired immunodeficiency syndrome	8.65e-05	0.00105	CcSEcCtD
Sulfamethoxazole—Cough—Delavirdine—acquired immunodeficiency syndrome	8.64e-05	0.00105	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	8.61e-05	0.00105	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	8.61e-05	0.00105	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	8.57e-05	0.00104	CcSEcCtD
Sulfamethoxazole—Anorexia—Indinavir—acquired immunodeficiency syndrome	8.52e-05	0.00104	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	8.46e-05	0.00103	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	8.44e-05	0.00103	CcSEcCtD
Sulfamethoxazole—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	8.43e-05	0.00103	CcSEcCtD
Sulfamethoxazole—Myalgia—Delavirdine—acquired immunodeficiency syndrome	8.43e-05	0.00103	CcSEcCtD
Sulfamethoxazole—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	8.41e-05	0.00102	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	8.35e-05	0.00102	CcSEcCtD
Sulfamethoxazole—Nausea—Amprenavir—acquired immunodeficiency syndrome	8.3e-05	0.00101	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	8.3e-05	0.00101	CcSEcCtD
Sulfamethoxazole—Fatigue—Zidovudine—acquired immunodeficiency syndrome	8.29e-05	0.00101	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	8.28e-05	0.00101	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	8.27e-05	0.00101	CcSEcCtD
Sulfamethoxazole—Tension—Lamivudine—acquired immunodeficiency syndrome	8.25e-05	0.00101	CcSEcCtD
Sulfamethoxazole—Vertigo—Ritonavir—acquired immunodeficiency syndrome	8.22e-05	0.001	CcSEcCtD
Sulfamethoxazole—Asthenia—Nevirapine—acquired immunodeficiency syndrome	8.22e-05	0.001	CcSEcCtD
Sulfamethoxazole—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	8.2e-05	0.000999	CcSEcCtD
Sulfamethoxazole—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	8.19e-05	0.000998	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	8.17e-05	0.000996	CcSEcCtD
Sulfamethoxazole—Nervousness—Lamivudine—acquired immunodeficiency syndrome	8.16e-05	0.000995	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	8.15e-05	0.000993	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	8.14e-05	0.000992	CcSEcCtD
Sulfamethoxazole—Pruritus—Nevirapine—acquired immunodeficiency syndrome	8.1e-05	0.000987	CcSEcCtD
Sulfamethoxazole—Vomiting—Didanosine—acquired immunodeficiency syndrome	8.1e-05	0.000987	CcSEcCtD
Sulfamethoxazole—Insomnia—Indinavir—acquired immunodeficiency syndrome	8.08e-05	0.000985	CcSEcCtD
Sulfamethoxazole—Anorexia—Efavirenz—acquired immunodeficiency syndrome	8.05e-05	0.000981	CcSEcCtD
Sulfamethoxazole—Rash—Didanosine—acquired immunodeficiency syndrome	8.03e-05	0.000978	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	8.02e-05	0.000978	CcSEcCtD
Sulfamethoxazole—Dermatitis—Didanosine—acquired immunodeficiency syndrome	8.02e-05	0.000978	CcSEcCtD
Sulfamethoxazole—Cough—Ritonavir—acquired immunodeficiency syndrome	7.99e-05	0.000973	CcSEcCtD
Sulfamethoxazole—Headache—Didanosine—acquired immunodeficiency syndrome	7.98e-05	0.000972	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	7.97e-05	0.000971	CcSEcCtD
Sulfamethoxazole—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	7.96e-05	0.00097	CcSEcCtD
Sulfamethoxazole—Asthenia—Stavudine—acquired immunodeficiency syndrome	7.93e-05	0.000967	CcSEcCtD
Sulfamethoxazole—Convulsion—Ritonavir—acquired immunodeficiency syndrome	7.93e-05	0.000966	CcSEcCtD
Sulfamethoxazole—Vertigo—Saquinavir—acquired immunodeficiency syndrome	7.92e-05	0.000965	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	7.91e-05	0.000964	CcSEcCtD
Sulfamethoxazole—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	7.89e-05	0.000961	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	7.87e-05	0.000959	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	7.86e-05	0.000958	CcSEcCtD
Sulfamethoxazole—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	7.85e-05	0.000956	CcSEcCtD
Sulfamethoxazole—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	7.85e-05	0.000956	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	7.83e-05	0.000955	CcSEcCtD
Sulfamethoxazole—Pruritus—Stavudine—acquired immunodeficiency syndrome	7.82e-05	0.000953	CcSEcCtD
Sulfamethoxazole—Asthenia—Abacavir—acquired immunodeficiency syndrome	7.81e-05	0.000952	CcSEcCtD
Sulfamethoxazole—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	7.79e-05	0.00095	CcSEcCtD
Sulfamethoxazole—Myalgia—Ritonavir—acquired immunodeficiency syndrome	7.79e-05	0.00095	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	7.77e-05	0.000947	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	7.74e-05	0.000943	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	7.72e-05	0.00094	CcSEcCtD
Sulfamethoxazole—Pruritus—Abacavir—acquired immunodeficiency syndrome	7.71e-05	0.000939	CcSEcCtD
Sulfamethoxazole—Fatigue—Indinavir—acquired immunodeficiency syndrome	7.71e-05	0.000939	CcSEcCtD
Sulfamethoxazole—Anorexia—Delavirdine—acquired immunodeficiency syndrome	7.7e-05	0.000938	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	7.69e-05	0.000937	CcSEcCtD
Sulfamethoxazole—Cough—Saquinavir—acquired immunodeficiency syndrome	7.69e-05	0.000937	CcSEcCtD
Sulfamethoxazole—Angioedema—Lamivudine—acquired immunodeficiency syndrome	7.68e-05	0.000936	CcSEcCtD
Sulfamethoxazole—Insomnia—Efavirenz—acquired immunodeficiency syndrome	7.64e-05	0.000931	CcSEcCtD
Sulfamethoxazole—Urticaria—Zidovudine—acquired immunodeficiency syndrome	7.63e-05	0.00093	CcSEcCtD
Sulfamethoxazole—Convulsion—Saquinavir—acquired immunodeficiency syndrome	7.63e-05	0.00093	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	7.6e-05	0.000926	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	7.6e-05	0.000926	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	7.59e-05	0.000925	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	7.56e-05	0.000922	CcSEcCtD
Sulfamethoxazole—Nausea—Didanosine—acquired immunodeficiency syndrome	7.56e-05	0.000922	CcSEcCtD
Sulfamethoxazole—Vertigo—Lamivudine—acquired immunodeficiency syndrome	7.55e-05	0.00092	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	7.53e-05	0.000917	CcSEcCtD
Sulfamethoxazole—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	7.52e-05	0.000917	CcSEcCtD
Sulfamethoxazole—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	7.5e-05	0.000914	CcSEcCtD
Sulfamethoxazole—Myalgia—Saquinavir—acquired immunodeficiency syndrome	7.5e-05	0.000914	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	7.45e-05	0.000908	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	7.45e-05	0.000908	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	7.43e-05	0.000906	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	7.36e-05	0.000897	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	7.34e-05	0.000894	CcSEcCtD
Sulfamethoxazole—Cough—Lamivudine—acquired immunodeficiency syndrome	7.33e-05	0.000894	CcSEcCtD
Sulfamethoxazole—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	7.33e-05	0.000894	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	7.33e-05	0.000893	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	7.32e-05	0.000891	CcSEcCtD
Sulfamethoxazole—Dizziness—Stavudine—acquired immunodeficiency syndrome	7.31e-05	0.000891	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	7.31e-05	0.00089	CcSEcCtD
Sulfamethoxazole—Insomnia—Delavirdine—acquired immunodeficiency syndrome	7.31e-05	0.00089	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	7.29e-05	0.000888	CcSEcCtD
Sulfamethoxazole—Convulsion—Lamivudine—acquired immunodeficiency syndrome	7.28e-05	0.000887	CcSEcCtD
Sulfamethoxazole—Vomiting—Nevirapine—acquired immunodeficiency syndrome	7.28e-05	0.000887	CcSEcCtD
Sulfamethoxazole—Fatigue—Efavirenz—acquired immunodeficiency syndrome	7.28e-05	0.000887	CcSEcCtD
Sulfamethoxazole—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	7.26e-05	0.000884	CcSEcCtD
Sulfamethoxazole—Rash—Nevirapine—acquired immunodeficiency syndrome	7.22e-05	0.00088	CcSEcCtD
Sulfamethoxazole—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	7.21e-05	0.000879	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	7.2e-05	0.000878	CcSEcCtD
Sulfamethoxazole—Dizziness—Abacavir—acquired immunodeficiency syndrome	7.2e-05	0.000878	CcSEcCtD
Sulfamethoxazole—Headache—Nevirapine—acquired immunodeficiency syndrome	7.17e-05	0.000874	CcSEcCtD
Sulfamethoxazole—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	7.16e-05	0.000872	CcSEcCtD
Sulfamethoxazole—Myalgia—Lamivudine—acquired immunodeficiency syndrome	7.16e-05	0.000872	CcSEcCtD
Sulfamethoxazole—Anorexia—Ritonavir—acquired immunodeficiency syndrome	7.12e-05	0.000868	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	7.11e-05	0.000867	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	7.11e-05	0.000866	CcSEcCtD
Sulfamethoxazole—Urticaria—Indinavir—acquired immunodeficiency syndrome	7.1e-05	0.000865	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	7.06e-05	0.000861	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	7.06e-05	0.000861	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	7.05e-05	0.000859	CcSEcCtD
Sulfamethoxazole—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	7.05e-05	0.000859	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	7.04e-05	0.000858	CcSEcCtD
Sulfamethoxazole—Vomiting—Stavudine—acquired immunodeficiency syndrome	7.03e-05	0.000857	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	7.02e-05	0.000856	CcSEcCtD
Sulfamethoxazole—Rash—Nelfinavir—acquired immunodeficiency syndrome	6.99e-05	0.000852	CcSEcCtD
Sulfamethoxazole—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	6.99e-05	0.000851	CcSEcCtD
Sulfamethoxazole—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	6.98e-05	0.000851	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	6.97e-05	0.00085	CcSEcCtD
Sulfamethoxazole—Rash—Stavudine—acquired immunodeficiency syndrome	6.97e-05	0.000849	CcSEcCtD
Sulfamethoxazole—Fatigue—Delavirdine—acquired immunodeficiency syndrome	6.97e-05	0.000849	CcSEcCtD
Sulfamethoxazole—Dermatitis—Stavudine—acquired immunodeficiency syndrome	6.96e-05	0.000849	CcSEcCtD
Sulfamethoxazole—Headache—Nelfinavir—acquired immunodeficiency syndrome	6.95e-05	0.000847	CcSEcCtD
Sulfamethoxazole—Headache—Stavudine—acquired immunodeficiency syndrome	6.93e-05	0.000844	CcSEcCtD
Sulfamethoxazole—Vomiting—Abacavir—acquired immunodeficiency syndrome	6.93e-05	0.000844	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	6.9e-05	0.000841	CcSEcCtD
Sulfamethoxazole—Asthenia—Zidovudine—acquired immunodeficiency syndrome	6.89e-05	0.00084	CcSEcCtD
Sulfamethoxazole—Rash—Abacavir—acquired immunodeficiency syndrome	6.87e-05	0.000837	CcSEcCtD
Sulfamethoxazole—Dermatitis—Abacavir—acquired immunodeficiency syndrome	6.86e-05	0.000836	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	6.86e-05	0.000836	CcSEcCtD
Sulfamethoxazole—Anorexia—Saquinavir—acquired immunodeficiency syndrome	6.85e-05	0.000835	CcSEcCtD
Sulfamethoxazole—Headache—Abacavir—acquired immunodeficiency syndrome	6.82e-05	0.000831	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	6.81e-05	0.000829	CcSEcCtD
Sulfamethoxazole—Nausea—Nevirapine—acquired immunodeficiency syndrome	6.8e-05	0.000829	CcSEcCtD
Sulfamethoxazole—Pruritus—Zidovudine—acquired immunodeficiency syndrome	6.8e-05	0.000828	CcSEcCtD
Sulfamethoxazole—Insomnia—Ritonavir—acquired immunodeficiency syndrome	6.76e-05	0.000823	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	6.73e-05	0.00082	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	6.72e-05	0.000818	CcSEcCtD
Sulfamethoxazole—Urticaria—Efavirenz—acquired immunodeficiency syndrome	6.71e-05	0.000817	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	6.68e-05	0.000813	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	6.68e-05	0.000813	CcSEcCtD
Sulfamethoxazole—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	6.66e-05	0.000812	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	6.66e-05	0.000812	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	6.61e-05	0.000805	CcSEcCtD
Sulfamethoxazole—Nausea—Nelfinavir—acquired immunodeficiency syndrome	6.59e-05	0.000803	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	6.58e-05	0.000802	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	6.58e-05	0.000801	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	6.58e-05	0.000801	CcSEcCtD
Sulfamethoxazole—Nausea—Stavudine—acquired immunodeficiency syndrome	6.57e-05	0.0008	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	6.55e-05	0.000798	CcSEcCtD
Sulfamethoxazole—Anorexia—Lamivudine—acquired immunodeficiency syndrome	6.54e-05	0.000797	CcSEcCtD
Sulfamethoxazole—Insomnia—Saquinavir—acquired immunodeficiency syndrome	6.5e-05	0.000793	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	6.49e-05	0.000791	CcSEcCtD
Sulfamethoxazole—Nausea—Abacavir—acquired immunodeficiency syndrome	6.47e-05	0.000788	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	6.45e-05	0.000786	CcSEcCtD
Sulfamethoxazole—Fatigue—Ritonavir—acquired immunodeficiency syndrome	6.44e-05	0.000785	CcSEcCtD
Sulfamethoxazole—Urticaria—Delavirdine—acquired immunodeficiency syndrome	6.42e-05	0.000782	CcSEcCtD
Sulfamethoxazole—Asthenia—Indinavir—acquired immunodeficiency syndrome	6.41e-05	0.000781	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	6.41e-05	0.000781	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	6.39e-05	0.000778	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	6.39e-05	0.000778	CcSEcCtD
Sulfamethoxazole—Dizziness—Zidovudine—acquired immunodeficiency syndrome	6.35e-05	0.000774	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	6.33e-05	0.000771	CcSEcCtD
Sulfamethoxazole—Pruritus—Indinavir—acquired immunodeficiency syndrome	6.32e-05	0.00077	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	6.25e-05	0.000762	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	6.25e-05	0.000762	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	6.22e-05	0.000758	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	6.21e-05	0.000756	CcSEcCtD
Sulfamethoxazole—Insomnia—Lamivudine—acquired immunodeficiency syndrome	6.2e-05	0.000756	CcSEcCtD
Sulfamethoxazole—Fatigue—Saquinavir—acquired immunodeficiency syndrome	6.2e-05	0.000755	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	6.12e-05	0.000745	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	6.11e-05	0.000745	CcSEcCtD
Sulfamethoxazole—Vomiting—Zidovudine—acquired immunodeficiency syndrome	6.11e-05	0.000745	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	6.11e-05	0.000744	CcSEcCtD
Sulfamethoxazole—Rash—Zidovudine—acquired immunodeficiency syndrome	6.06e-05	0.000738	CcSEcCtD
Sulfamethoxazole—Asthenia—Efavirenz—acquired immunodeficiency syndrome	6.06e-05	0.000738	CcSEcCtD
Sulfamethoxazole—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	6.05e-05	0.000738	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	6.04e-05	0.000736	CcSEcCtD
Sulfamethoxazole—Headache—Zidovudine—acquired immunodeficiency syndrome	6.02e-05	0.000734	CcSEcCtD
Sulfamethoxazole—Pruritus—Efavirenz—acquired immunodeficiency syndrome	5.97e-05	0.000728	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	5.96e-05	0.000727	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	5.95e-05	0.000725	CcSEcCtD
Sulfamethoxazole—Urticaria—Ritonavir—acquired immunodeficiency syndrome	5.94e-05	0.000723	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	5.92e-05	0.000722	CcSEcCtD
Sulfamethoxazole—Fatigue—Lamivudine—acquired immunodeficiency syndrome	5.91e-05	0.000721	CcSEcCtD
Sulfamethoxazole—Dizziness—Indinavir—acquired immunodeficiency syndrome	5.91e-05	0.00072	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	5.91e-05	0.00072	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	5.91e-05	0.00072	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	5.88e-05	0.000717	CcSEcCtD
Sulfamethoxazole—Asthenia—Delavirdine—acquired immunodeficiency syndrome	5.8e-05	0.000706	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	5.78e-05	0.000704	CcSEcCtD
Sulfamethoxazole—Pruritus—Delavirdine—acquired immunodeficiency syndrome	5.72e-05	0.000696	CcSEcCtD
Sulfamethoxazole—Urticaria—Saquinavir—acquired immunodeficiency syndrome	5.71e-05	0.000696	CcSEcCtD
Sulfamethoxazole—Nausea—Zidovudine—acquired immunodeficiency syndrome	5.71e-05	0.000696	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	5.68e-05	0.000693	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	5.68e-05	0.000693	CcSEcCtD
Sulfamethoxazole—Vomiting—Indinavir—acquired immunodeficiency syndrome	5.68e-05	0.000692	CcSEcCtD
Sulfamethoxazole—Rash—Indinavir—acquired immunodeficiency syndrome	5.63e-05	0.000687	CcSEcCtD
Sulfamethoxazole—Dermatitis—Indinavir—acquired immunodeficiency syndrome	5.63e-05	0.000686	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	5.61e-05	0.000684	CcSEcCtD
Sulfamethoxazole—Headache—Indinavir—acquired immunodeficiency syndrome	5.6e-05	0.000682	CcSEcCtD
Sulfamethoxazole—Dizziness—Efavirenz—acquired immunodeficiency syndrome	5.58e-05	0.00068	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	5.53e-05	0.000674	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	5.5e-05	0.000671	CcSEcCtD
Sulfamethoxazole—Urticaria—Lamivudine—acquired immunodeficiency syndrome	5.45e-05	0.000664	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	5.42e-05	0.000661	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	5.42e-05	0.000661	CcSEcCtD
Sulfamethoxazole—Vomiting—Efavirenz—acquired immunodeficiency syndrome	5.37e-05	0.000654	CcSEcCtD
Sulfamethoxazole—Asthenia—Ritonavir—acquired immunodeficiency syndrome	5.36e-05	0.000653	CcSEcCtD
Sulfamethoxazole—Dizziness—Delavirdine—acquired immunodeficiency syndrome	5.34e-05	0.000651	CcSEcCtD
Sulfamethoxazole—Rash—Efavirenz—acquired immunodeficiency syndrome	5.32e-05	0.000649	CcSEcCtD
Sulfamethoxazole—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	5.32e-05	0.000648	CcSEcCtD
Sulfamethoxazole—Nausea—Indinavir—acquired immunodeficiency syndrome	5.31e-05	0.000647	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	5.3e-05	0.000646	CcSEcCtD
Sulfamethoxazole—Headache—Efavirenz—acquired immunodeficiency syndrome	5.29e-05	0.000645	CcSEcCtD
Sulfamethoxazole—Pruritus—Ritonavir—acquired immunodeficiency syndrome	5.29e-05	0.000644	CcSEcCtD
Sulfamethoxazole—Asthenia—Saquinavir—acquired immunodeficiency syndrome	5.16e-05	0.000629	CcSEcCtD
Sulfamethoxazole—Vomiting—Delavirdine—acquired immunodeficiency syndrome	5.14e-05	0.000626	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	5.11e-05	0.000623	CcSEcCtD
Sulfamethoxazole—Rash—Delavirdine—acquired immunodeficiency syndrome	5.09e-05	0.000621	CcSEcCtD
Sulfamethoxazole—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	5.09e-05	0.00062	CcSEcCtD
Sulfamethoxazole—Pruritus—Saquinavir—acquired immunodeficiency syndrome	5.09e-05	0.00062	CcSEcCtD
Sulfamethoxazole—Headache—Delavirdine—acquired immunodeficiency syndrome	5.06e-05	0.000617	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	5.05e-05	0.000616	CcSEcCtD
Sulfamethoxazole—Nausea—Efavirenz—acquired immunodeficiency syndrome	5.02e-05	0.000611	CcSEcCtD
Sulfamethoxazole—Dizziness—Ritonavir—acquired immunodeficiency syndrome	4.94e-05	0.000602	CcSEcCtD
Sulfamethoxazole—Asthenia—Lamivudine—acquired immunodeficiency syndrome	4.92e-05	0.0006	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	4.92e-05	0.0006	CcSEcCtD
Sulfamethoxazole—Pruritus—Lamivudine—acquired immunodeficiency syndrome	4.85e-05	0.000591	CcSEcCtD
Sulfamethoxazole—Nausea—Delavirdine—acquired immunodeficiency syndrome	4.8e-05	0.000585	CcSEcCtD
Sulfamethoxazole—Dizziness—Saquinavir—acquired immunodeficiency syndrome	4.76e-05	0.000579	CcSEcCtD
Sulfamethoxazole—Vomiting—Ritonavir—acquired immunodeficiency syndrome	4.75e-05	0.000579	CcSEcCtD
Sulfamethoxazole—Rash—Ritonavir—acquired immunodeficiency syndrome	4.71e-05	0.000574	CcSEcCtD
Sulfamethoxazole—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	4.71e-05	0.000573	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	4.69e-05	0.000572	CcSEcCtD
Sulfamethoxazole—Headache—Ritonavir—acquired immunodeficiency syndrome	4.68e-05	0.00057	CcSEcCtD
Sulfamethoxazole—Vomiting—Saquinavir—acquired immunodeficiency syndrome	4.57e-05	0.000557	CcSEcCtD
Sulfamethoxazole—Dizziness—Lamivudine—acquired immunodeficiency syndrome	4.54e-05	0.000553	CcSEcCtD
Sulfamethoxazole—Rash—Saquinavir—acquired immunodeficiency syndrome	4.53e-05	0.000552	CcSEcCtD
Sulfamethoxazole—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	4.53e-05	0.000552	CcSEcCtD
Sulfamethoxazole—Headache—Saquinavir—acquired immunodeficiency syndrome	4.5e-05	0.000549	CcSEcCtD
Sulfamethoxazole—Nausea—Ritonavir—acquired immunodeficiency syndrome	4.44e-05	0.000541	CcSEcCtD
Sulfamethoxazole—Vomiting—Lamivudine—acquired immunodeficiency syndrome	4.36e-05	0.000531	CcSEcCtD
Sulfamethoxazole—Rash—Lamivudine—acquired immunodeficiency syndrome	4.33e-05	0.000527	CcSEcCtD
Sulfamethoxazole—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	4.32e-05	0.000527	CcSEcCtD
Sulfamethoxazole—Headache—Lamivudine—acquired immunodeficiency syndrome	4.3e-05	0.000524	CcSEcCtD
Sulfamethoxazole—Nausea—Saquinavir—acquired immunodeficiency syndrome	4.27e-05	0.00052	CcSEcCtD
Sulfamethoxazole—Nausea—Lamivudine—acquired immunodeficiency syndrome	4.07e-05	0.000497	CcSEcCtD
